Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. (AMPE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AMPE · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2024Report Date: Mar 27, 2024Next Earnings Date
EPS & Revenue vs. Estimates
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 11, 2026 | -$6.00 | — | — | — | $0.00B | — |
| ◌ Q2 FY2026 | May 29, 2026 | -$6.00 | — | — | — | $0.00B | — |
| ◌ Q2 FY2026 | Apr 1, 2026 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | Apr 28, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Mar 28, 2025 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Nov 13, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Sep 30, 2024 | — | — | — | — | — | — |
| — Q1 FY2024 | Mar 27, 2024 | — | -$2.48 | — | $0.00B | — | — |
Analyst Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2029 | $-6.00 | $-6.00 | $-6.00 | 1 |
| Q2 FY2029 | $-6.00 | $-6.00 | $-6.00 | 1 |
| Q1 FY2029 | $-6.00 | $-6.00 | $-6.00 | 1 |
| Q4 FY2028 | $-6.00 | $-6.00 | $-6.00 | 1 |
| Q3 FY2028 | $-6.00 | $-6.00 | $-6.00 | 1 |
| Q2 FY2028 | $-6.00 | $-6.00 | $-6.00 | 1 |
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2024 | Mar 27, 2024 | — | $0.81 | $0.82 | +1.05% |
| ▲ Q4 FY2023 | Nov 14, 2023 | +74.5% | $2.60 | $2.90 | +11.54% |
| ▲ Q3 FY2023 | Aug 8, 2023 | +70.0% | $4.20 | $4.40 | +4.76% |
| ▲ Q2 FY2023 | May 8, 2023 | +13.3% | $4.20 | $4.60 | +9.52% |
| ▲ Q1 FY2023 | Mar 27, 2023 | +40.0% | $5.00 | $4.80 | -4.00% |
About Earnings & Data Methodology
Ampio Pharmaceuticals, Inc. (AMPE) most recently reported earnings on March 27, 2024 for Q1 FY2024, posting EPS of $-2.48 (in line with the analyst consensus of —). AMPE has beaten EPS estimates for 4 consecutive quarters. The next AMPE earnings date is expected around September 1, 2026.
Each quarter, investors track AMPE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AMPE revenue tab →
Frequently asked questions
AMPE earnings · 4 questionsAmpio Pharmaceuticals, Inc.'s next earnings report is expected around September 1, 2026. AMPE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AMPE historically reports after market close (AMC).
▸ Source: FMP · Ampio Pharmaceuticals, Inc. SEC filings · US GAAP · Ampio Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026